Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report) shares passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $2.51 and traded as low as $2.20. Organicell Regenerative Medicine shares last traded at $2.30, with a volume of 12,602 shares changing hands.
Organicell Regenerative Medicine Trading Up 3.6%
The business’s fifty day moving average is $2.51 and its 200 day moving average is $2.00.
Organicell Regenerative Medicine Company Profile
Organicell Regenerative Medicine, Inc is a clinical‐stage biotechnology company dedicated to the development and commercialization of cell and exosome‐based therapeutics for a variety of inflammatory and degenerative medical conditions. Leveraging its proprietary placental and amniotic tissue–derived platform, the company isolates and purifies extracellular vesicles (EVs) and mesenchymal‐like cells, which are studied for their ability to modulate immune response and promote tissue repair. With an emphasis on regenerative medicine, Organicell’s research efforts aim to translate novel biologics into scalable treatments.
The company’s pipeline is anchored by exosome‐centered product candidates that target pulmonary, ophthalmic, and musculoskeletal indications.
Featured Articles
- Five stocks we like better than Organicell Regenerative Medicine
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
